Corticosteroid toxicity in neuro-oncology patients
- 155 Downloads
Hospital charts from 59 patients with intracranial malignancy or epidural spinal cord compression were reviewed to establish the frequency of clinically important corticosteroid toxicities and to determine treatment or patient characteristics which were predictive for toxicity. Thirty patients (51%) developed at least one steroid toxicity and eleven (19%) required hospital admission for diagnosis and/or management of steroid-related complications. In this retrospective analysis the duration of steroid therapy and the total administered dose predicted for toxicity. Patients with toxicity also had a significant fall in the serum albumin level. Important corticosteroid toxicity occurs frequently in neuro-oncology patients. Further research should be directed at developing non-toxic alternatives to corticosteroids.
Key wordscorticosteroid brain metastases spinal metastases
Unable to display preview. Download preview PDF.
- 1.Dukes MNG: Meyler's side effects of drugs. Excerpta Medica Amsterdam, Oxford, 1975, pp 812–840Google Scholar
- 3.Renaudin J, Fewer D, Wilson CB, Boldrey EB, Calogero J, Enot KJ: Dose dependency of Decadron in patients with partially excised brain tumors. J Neurosurg 39:302–305, 1977Google Scholar
- 5.Slatkin NE, Posner JB: Management of spinal epidural metastases. Clin Neurosurg 3:698–716, 1982Google Scholar
- 10.The Boston Collaborative Drug Surveillance Program. Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther 13:694–698, 1972Google Scholar